Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Jul;94(26):e1055.
doi: 10.1097/MD.0000000000001055.

The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies

Luyao Chen  1 , Hongzhao Li, Liangyou Gu, Xin Ma, Xintao Li, Yu Gao, Yu Zhang, Donglai Shen, Yang Fan, Baojun Wang, Xu Bao, Xu Zhang
Affiliations
Meta-Analysis

The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies

Luyao Chen et al. Medicine (Baltimore). 2015 Jul.

Abstract

Previous studies that investigated the relationship between DM and survival in renal cell carcinoma (RCC) patients reported inconsistent findings. Hence, we conducted a meta-analysis to obtain a more precise evaluation of the prognostic significance of DM in RCC. A systematic review was conducted with PubMed, Embase, and Web of Science to identify relevant articles that evaluated the effect of DM on RCC patients. Based on the inclusion and quality assessment criteria, 18 studies were eligible for the meta-analysis. Pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) for overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS) were calculated by standard meta-analysis techniques. The results suggested that DM was associated with poor OS (HR 1.56, 95% CI, 1.35-1.81, P < 0.001), poor CSS (HR 2.03, 95% CI, 1.37-3.01, P < 0.001), and poor RFS (HR 1.73, 95% CI, 1.25-2.39, P = 0.012). In addition, for patients with localized RCC, patients with clear cell RCC, or patients receiving nephrectomy, DM was associated with both poor OS and CSS by subgroup analyses. Our study revealed that there was a significant negative impact of DM on OS, CSS, and RFS in RCC patients. Therefore, more attention should be paid to RCC patients with preexisting DM because of their poor prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Flow chart of study selection.
FIGURE 2
FIGURE 2
Forest plot of studies evaluating the association between diabetes mellitus and overall survival of renal cell carcinoma.
FIGURE 3
FIGURE 3
Forest plot of studies evaluating the association between diabetes mellitus and cancer-specific survival of renal cell carcinoma.
FIGURE 4
FIGURE 4
Forest plot of studies evaluating the association between diabetes mellitus and recurrence-free survival of renal cell carcinoma.
FIGURE 5
FIGURE 5
Funnel plots for the evaluation of potential publication bias. A, Overall survival; B, cancer-specific survival; C, recurrence-free survival.
See this image and copyright information in PMC

References

    1. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr Opin Urol 2007; 17:303–308. - PubMed
    1. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62:220–241. - PubMed
    1. Choi Y, Park B, Jeong BC, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer 2013; 132:625–634. - PubMed
    1. Park YH, Lee JK, Kim KM, et al. Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma. J Urol 2014; 192:1043–1049. - PubMed
    1. Choi SK, Min GE, Jeon SH, et al. Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy. Mol Clin Oncol 2013; 1:365–368. - PMC - PubMed